Funding
← Back to your selection

NVIDIA

Activity from announced rounds

Activity in this selectionBiotech

NVIDIA builds the processors, systems and software used to train and run AI. Its startup relationships combine corporate investment with access to an accelerated-computing ecosystem.

Founders can approach its venture capital arm, NVentures, for investment in technology businesses. NVIDIA also operates Inception, a free programme offering technical training, selected hardware and software pricing benefits, and introductions through its VC Alliance.

Inception has no equity requirement. Applicants need an incorporated company, a working website, an actively involved founder and a use case for NVIDIA technology; a startup can join before it has revenue or starts using NVIDIA products. Membership provides development resources rather than an automatic investment.

Sources
Rounds participated in
3
Confirmed lead rounds
0
All roles disclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$200M
2 disclosed · full round size, not this investor’s share

By stage

Series B1
Series C+1
Undisclosed1

By primary sector

Biotech3

By country

United States2
United Kingdom1

Rounds

3 in this selection
Boltz

Boltz builds biomolecular AI models and software for molecular design and drug-discovery research.

UndisclosedPlanned strategic investment
Participant
Basecamp Research

Basecamp Research builds biological AI models from genomic data to help design therapeutics, including protein-based medicines.

$140MSeries C
Participant
Superluminal Medicines

Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity.

$60MSeries B
Participant